MeSH term
Frequency | Condition_Probility | Chromatography, High Pressure Liquid | 3 | 0.0 |
Humans | 128 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Adolescent | 14 | 0.0 |
Adult | 27 | 0.0 |
Aged | 17 | 0.0 |
Female | 47 | 0.0 |
Genetic Screening | 5 | 0.0 |
Genotype | 12 | 0.0 |
Linkage (Genetics)/genetics | 5 | 1.0 |
Male | 48 | 0.0 |
Membrane Proteins/genetics | 13 | 3.0 |
Middle Aged | 21 | 0.0 |
Pedigree | 28 | 0.0 |
Proteins/genetics | 19 | 2.0 |
Research Support, Non-U.S. Gov't | 103 | 0.0 |
Alleles | 9 | 0.0 |
DNA/genetics | 3 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Phenotype | 15 | 0.0 |
Polymorphism, Genetic/genetics | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Cell Line | 10 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Phosphorylation | 4 | 0.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Signal Transduction | 5 | 0.0 |
Animals | 47 | 0.0 |
Cell Division/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Membrane Proteins/genetics/metabolism | 2 | 1.0 |
Mice | 20 | 0.0 |
Mice, Knockout | 9 | 0.0 |
Mutation/genetics | 7 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics/metabolism | 2 | 66.0 |
Proteins/genetics/*metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 48 | 0.0 |
Calcium Channels/genetics | 3 | 11.0 |
Comparative Study | 8 | 0.0 |
Japan/epidemiology | 2 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics | 35 | 31.0 |
Proteins/*genetics | 21 | 1.0 |
Disease Models, Animal | 9 | 0.0 |
Membrane Proteins/*genetics | 32 | 3.0 |
Polycystic Kidney Diseases/*genetics | 8 | 21.0 |
Child | 9 | 0.0 |
Child, Preschool | 7 | 0.0 |
Cysts/*genetics | 2 | 50.0 |
Genes, Dominant | 3 | 0.0 |
Membrane Proteins/biosynthesis/*genetics | 2 | 4.0 |
Pregnancy | 3 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
DNA Mutational Analysis | 13 | 0.0 |
Protein Structure, Tertiary/genetics/physiology | 2 | 6.0 |
Signal Transduction/genetics/physiology | 2 | 4.0 |
Amino Acid Sequence | 17 | 0.0 |
Chromosome Mapping | 10 | 0.0 |
Molecular Sequence Data | 27 | 0.0 |
Organ Specificity | 5 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
Membrane Proteins/genetics/physiology | 3 | 13.0 |
Mutation | 15 | 0.0 |
*Alleles | 2 | 0.0 |
Chromosomes, Human, Pair 4/*genetics | 3 | 3.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Physical Chromosome Mapping | 2 | 0.0 |
English Abstract | 7 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
*Linkage (Genetics) | 6 | 0.0 |
Microsatellite Repeats/*genetics | 3 | 1.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Linkage (Genetics) | 16 | 0.0 |
Microsatellite Repeats | 5 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Polymorphism, Genetic | 6 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
*Mutation | 13 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics/pathology | 4 | 57.0 |
*Calcium Signaling | 2 | 4.0 |
Endoplasmic Reticulum/metabolism | 2 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Family Health | 2 | 0.0 |
Genetic Heterogeneity | 5 | 1.0 |
Genetic Markers | 16 | 0.0 |
Korea | 2 | 0.0 |
Lod Score | 7 | 0.0 |
Germ-Line Mutation/genetics | 3 | 4.0 |
Mutation/*genetics | 6 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
Gene Expression | 8 | 0.0 |
Membrane Proteins/genetics/*metabolism | 5 | 1.0 |
Protein Binding | 5 | 0.0 |
Protein Transport | 3 | 0.0 |
Proteins/chemistry/genetics/*metabolism | 2 | 2.0 |
Molecular Biology | 2 | 0.0 |
Proteins/genetics/physiology | 6 | 9.0 |
Gene Frequency | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Base Sequence | 17 | 0.0 |
Haplotypes | 2 | 0.0 |
Heterozygote | 5 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Polycystic Kidney, Autosomal Dominant/genetics/*metabolism | 2 | 50.0 |
Transfection | 4 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Membrane Proteins/*genetics/*metabolism | 2 | 4.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
Swine | 2 | 0.0 |
Chromosomes, Human, Pair 16/genetics | 2 | 2.0 |
Chromosomes, Human, Pair 4/genetics | 5 | 6.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics/physiopathology | 3 | 75.0 |
Cell Membrane/chemistry | 2 | 1.0 |
*Gene Expression | 2 | 0.0 |
Glycosylation | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Rats | 3 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics/*physiopathology | 2 | 100.0 |
Cloning, Molecular | 9 | 0.0 |
Exons | 6 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Introns | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Polycystic Kidney, Autosomal Dominant/genetics | 6 | 40.0 |
Sequence Deletion | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Chromosomes, Human, Pair 16 | 3 | 2.0 |
Chromosomes, Human, Pair 4 | 4 | 3.0 |
Clone Cells | 2 | 0.0 |
Exons/genetics | 6 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*genetics/*pathology | 2 | 100.0 |
Polymorphism, Single Nucleotide/genetics | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 8 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Sequence Homology, Amino Acid | 10 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
Severity of Illness Index | 4 | 0.0 |
Calcium Channels/*genetics | 2 | 2.0 |
DNA/analysis | 3 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
*Frameshift Mutation | 2 | 1.0 |
Prognosis | 2 | 0.0 |
Loss of Heterozygosity | 4 | 0.0 |
Loss of Heterozygosity/*genetics | 2 | 2.0 |
Membrane Proteins/chemistry/*genetics/metabolism | 2 | 10.0 |
*Membrane Glycoproteins | 2 | 0.0 |
*Phosphoproteins | 2 | 1.0 |
Sequence Alignment | 4 | 0.0 |
Exons/*genetics | 2 | 0.0 |
Calcium-Binding Proteins/metabolism | 2 | 2.0 |
*RNA Splicing | 2 | 0.0 |
Proteins/chemistry | 3 | 6.0 |
DNA Primers | 2 | 0.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Proteins/*genetics/metabolism | 3 | 1.0 |
*Models, Genetic | 2 | 1.0 |
Infant, Newborn | 5 | 0.0 |
Membrane Proteins/*physiology | 2 | 1.0 |
Proteins/*physiology | 2 | 1.0 |
Survival Analysis | 2 | 0.0 |
DNA/genetics/isolation & purification | 2 | 0.0 |
Germ-Line Mutation | 3 | 0.0 |
Kidney/metabolism | 3 | 0.0 |
Liver/metabolism | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Polycystic Kidney, Autosomal Dominant/*metabolism | 2 | 50.0 |
Time Factors | 2 | 0.0 |
*Chromosomes, Human, Pair 16 | 3 | 1.0 |
*Chromosomes, Human, Pair 4 | 5 | 2.0 |
Restriction Mapping | 3 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Kidney Failure, Chronic/etiology | 3 | 11.0 |
Polycystic Kidney, Autosomal Dominant/*complications/genetics | 2 | 100.0 |
Kidney | 2 | 0.0 |
Gene Expression/physiology | 2 | 0.0 |
Infant | 3 | 0.0 |
Polycystic Kidney, Autosomal Dominant/epidemiology/*genetics | 2 | 40.0 |
Czech Republic/epidemiology | 2 | 13.0 |
Polycystic Kidney, Autosomal Dominant/*diagnosis/epidemiology/*genetics | 2 | 100.0 |
Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Membrane Proteins/chemistry/*genetics | 5 | 7.0 |
Models, Molecular | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
*Genetic Heterogeneity | 2 | 1.0 |
DNA, Complementary | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Chromosome Mapping/methods | 2 | 1.0 |
Tomography, X-Ray Computed | 3 | 0.0 |
Age of Onset | 3 | 0.0 |
Polycystic Kidney Diseases/*diagnosis/*genetics | 2 | 100.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Calcium/*metabolism | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Cilia/*physiology | 2 | 25.0 |
Receptors, Cell Surface/agonists/*metabolism | 2 | 50.0 |
Signal Transduction/physiology | 2 | 0.0 |
